Page last updated: 2024-11-05

tranexamic acid and Craniofacial Abnormalities

tranexamic acid has been researched along with Craniofacial Abnormalities in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Craniofacial Abnormalities: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.

Research Excerpts

ExcerptRelevanceReference
"The aim was to utilize the Pediatric Craniofacial Surgery Perioperative Registry database to identify the safety profile of antifibrinolytic therapy for cranial vault reconstructive surgery by reporting the incidence of adverse events as they relate to exposure to tranexamic acid and aminocaproic acid compared to no exposure to antifibrinolytics."1.46Safety of antifibrinolytics in cranial vault reconstructive surgery: a report from the pediatric craniofacial collaborative group. ( Cladis, FP; Fernandez, AM; Glover, CD; Goobie, SM; Huang, H; Reddy, SK; Stricker, PA; Zurakowski, D, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goobie, SM1
Cladis, FP1
Glover, CD1
Huang, H1
Reddy, SK1
Fernandez, AM1
Zurakowski, D1
Stricker, PA1

Other Studies

1 other study available for tranexamic acid and Craniofacial Abnormalities

ArticleYear
Safety of antifibrinolytics in cranial vault reconstructive surgery: a report from the pediatric craniofacial collaborative group.
    Paediatric anaesthesia, 2017, Volume: 27, Issue:3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Child; Child, Preschool; Cooperati

2017